Revenue and profits soared year-over-year, led by Bio Chemical segment growth and strong demand for AI and pharmaceutical materials. The company improved margins, expanded capacity, and maintained robust liquidity, while continuing to invest in R&D and manage financial risks.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.